Mr. Gutman is a trial lawyer with over 20 years experience in state and federal courts in New York and New Jersey. A graduate of the Univeristy of Michigan Law School, he worked at two premier large firms before establishing his practice.
He is assisted on case preparation by Amy Schneider. She is a graduate of Princeton Univ and the Mass Inst. of Technology where she received her M.B.A.
Our goal is simple, provide high quality legal services with lean staffing and competitive hourly rates.
Our office has litigated multiple RICO fraud claims in state and federal court. We recently secured a substantial six figure settlement after our complaint survived multiple dismissal motions. Our blog provides practice tips. http://ricolawyer.org
We represented an attorney charged with participating in a RICO conspiracy to present exaggerated personal injury claims. A 5 year state prison sentence was recommended with 20 years possible. After filing pretrial motions challenging his alleged participation (noting others used the same medical professionals without penalty), the matter was resolved with a sentence of community service and probation. .
Our office has represented Fortune 500 companies as well as small closely held businesses. We served as local counsel for a Fortune 500 Company helping to secure dismissal of a
trade misappropriation claim from a former business partner, and have
litigated trademark and patent claims both for and against publicly held companies.
The office has also handled multiple class actions, with claims featured in national media such as Law360.
Prior to starting his office, Howard Gutman was a senior associate at a large New Jersey firm with a substantial part of his work handling asbestos litigation. Mr. Gutman wrote a book on lung cancer, now entering its second edition. He has done detailed research on particular cellular mutations in lung cancer and how they impact case preparation and assessment in occupational disease claims. counsel product liability. He is the author of an upcoming article in the New Jersey Law Journal on the impact of medical development in cancer research on asbestos defense.